The 2017 American College of Cardiology/ American Heart Association Clinical Practice Guideline for Blood Pressure: Implications for India.
作者信息
Agarwal Anubha, Huffman Mark D, Reddy K Srinath, Prabhakaran Dorairaj
机构信息
Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
出版信息
Natl Med J India. 2018 May-Jun;31(3):129-132. doi: 10.4103/0970-258X.255751.
Abstract
摘要
相似文献
1
The 2017 American College of Cardiology/ American Heart Association Clinical Practice Guideline for Blood Pressure: Implications for India.《2017年美国心脏病学会/美国心脏协会血压临床实践指南：对印度的影响》
Natl Med J India. 2018 May-Jun;31(3):129-132. doi: 10.4103/0970-258X.255751.
2
Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.2017年美国心脏协会/美国心脏病学会高血压指南的全球影响：来自印度的视角
Circulation. 2018 Feb 6;137(6):549-550. doi: 10.1161/CIRCULATIONAHA.117.032877.
3
Generalizability of Clinical Trials Supporting the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.支持 2017 年美国心脏病学会/美国心脏协会血压指南的临床试验的可推广性。
JAMA Intern Med. 2020 May 1;180(5):795-797. doi: 10.1001/jamainternmed.2020.0051.
4
Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.2017年美国心脏病学会/美国心脏协会高血压指南的全球影响：来自中国的视角
Circulation. 2018 Feb 6;137(6):546-548. doi: 10.1161/CIRCULATIONAHA.117.032890.
5
Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.2017年美国心脏协会/美国心脏病学会高血压指南的全球影响：来自日本的观点
Circulation. 2018 Feb 6;137(6):543-545. doi: 10.1161/CIRCULATIONAHA.117.032851.
6
Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.2017 年美国心脏病学会/美国心脏协会血压指南对亚洲下一个血压指南的影响。
Curr Hypertens Rep. 2019 Jan 10;21(1):2. doi: 10.1007/s11906-019-0906-2.
7
Aiming higher in hopes to achieve lower: the European Society of Cardiology/European Society of Hypertension versus the American College of Cardiology/American Heart Association guidelines for diagnosis and management of hypertension.期望更高以实现更低目标：欧洲心脏病学会/欧洲高血压学会与美国心脏病学会/美国心脏协会高血压诊断和管理指南对比
J Hum Hypertens. 2019 Sep;33(9):635-638. doi: 10.1038/s41371-019-0227-6. Epub 2019 Aug 20.
8
From the Editor.来自编辑
J Am Soc Hypertens. 2017 Dec;11(12):779-780. doi: 10.1016/j.jash.2017.11.006.
9
First-Year Anniversary of the 2017 Hypertension Guideline.2017年高血压指南发布一周年。
Circulation. 2018 Oct 23;138(17):1774-1776. doi: 10.1161/CIRCULATIONAHA.118.036981.
10
Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.欧美指南对高血压患病率、治疗和心血管代谢目标的影响。
J Hypertens. 2019 Jul;37(7):1393-1400. doi: 10.1097/HJH.0000000000002065.
引用本文的文献
1
World Heart Federation Roadmap for Hypertension - A 2021 Update.世界心脏联合会高血压路线图-2021 年更新版。
Glob Heart. 2021 Sep 10;16(1):63. doi: 10.5334/gh.1066. eCollection 2021.
本文引用的文献
1
Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults.印度的糖尿病和高血压：一项涉及 130 万成年人的全国代表性研究。
JAMA Intern Med. 2018 Mar 1;178(3):363-372. doi: 10.1001/jamainternmed.2017.8094.
2
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异：1990-2016 年印度各邦的疾病流行转变的流行病学差异，全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
3
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年医学会/美国药剂师协会/美国血液学会/美国预防心脏病学会/美国国家医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Hypertension. 2018 Jun;71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13.
4
Uses of polypills for cardiovascular disease and evidence to date.复方药物在心血管疾病中的应用及现有证据。
Lancet. 2017 Mar 11;389(10073):1055-1065. doi: 10.1016/S0140-6736(17)30553-6.
5
Risk scoring for the primary prevention of cardiovascular disease.心血管疾病一级预防的风险评分
Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4.
6
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.全球 1990-2015 年高血压和收缩压至少为 110 至 115mmHg 的负担
JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043.
7
Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review.低收入和中等收入国家与高收入国家高血压指南的差距：一项系统评价。
Hypertension. 2016 Dec;68(6):1328-1337. doi: 10.1161/HYPERTENSIONAHA.116.08290. Epub 2016 Oct 3.
8
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.心血管疾病风险中等的人群的血压降低。
N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2.
9
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
10
Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.用于预防心血管疾病的复方制剂（PolyIran）：一项实用整群随机对照试验的研究设计与原理
Eur J Prev Cardiol. 2015 Dec;22(12):1609-17. doi: 10.1177/2047487314550803. Epub 2014 Sep 17.
Zotero 插件